Revvity Inc. $RVTY Shares Acquired by Sei Investments Co.

Sei Investments Co. increased its holdings in shares of Revvity Inc. (NYSE:RVTY) by 82.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 703,406 shares of the company’s stock after buying an additional 318,368 shares during the period. Sei Investments Co.’s holdings in Revvity were worth $61,625,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently added to or reduced their stakes in the company. Ascentis Independent Advisors purchased a new stake in Revvity in the 1st quarter worth $29,000. CYBER HORNET ETFs LLC purchased a new position in Revvity during the second quarter valued at $32,000. Cromwell Holdings LLC lifted its holdings in Revvity by 141.4% during the fourth quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock valued at $33,000 after purchasing an additional 198 shares in the last quarter. MUFG Securities EMEA plc acquired a new stake in shares of Revvity in the second quarter valued at about $34,000. Finally, SJS Investment Consulting Inc. increased its stake in shares of Revvity by 5,210.0% during the first quarter. SJS Investment Consulting Inc. now owns 531 shares of the company’s stock worth $47,000 after purchasing an additional 521 shares in the last quarter. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Stock Down 2.3%

Shares of NYSE:RVTY opened at $110.56 on Friday. The firm has a market capitalization of $12.33 billion, a PE ratio of 52.90, a price-to-earnings-growth ratio of 2.17 and a beta of 1.09. Revvity Inc. has a 1 year low of $81.22 and a 1 year high of $118.30. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.72 and a quick ratio of 1.41. The firm’s 50-day moving average is $104.90 and its two-hundred day moving average is $99.61.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 EPS for the quarter, beating the consensus estimate of $1.02 by $0.04. The business had revenue of $711.12 million during the quarter, compared to analyst estimates of $704.07 million. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The business’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.01 earnings per share. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Analysts predict that Revvity Inc. will post 5.25 EPS for the current year.

Revvity Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be issued a dividend of $0.07 per share. The ex-dividend date is Friday, July 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity’s dividend payout ratio is 13.40%.

Wall Street Analyst Weigh In

Several research firms recently weighed in on RVTY. Robert W. Baird set a $117.00 price target on shares of Revvity in a research report on Wednesday, May 6th. Evercore reiterated an “outperform” rating and issued a $125.00 price objective on shares of Revvity in a report on Monday, July 6th. JPMorgan Chase & Co. dropped their price target on Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a research report on Wednesday, May 6th. The Goldman Sachs Group cut their price objective on shares of Revvity from $110.00 to $95.00 and set a “neutral” rating for the company in a research report on Tuesday, April 14th. Finally, TD Cowen restated a “buy” rating on shares of Revvity in a research report on Wednesday, July 15th. Four analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $108.92.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.